| Product Code: ETC12473442 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Finland continued to rely on imports of induced pluripotent stem cells in 2024, with the USA, Germany, UK, Austria, and New Zealand being the top exporting countries. The market showed high concentration with a very high Herfindahl-Hirschman Index (HHI) in 2024. Despite a strong compound annual growth rate (CAGR) of 24.17% from 2020 to 2024, there was a notable decline in growth from 2023 to 2024, with a negative growth rate of -20.18%. These trends suggest a complex market landscape for induced pluripotent stem cell imports in Finland.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Finland Induced Pluripotent Stem Cells Market Overview |
3.1 Finland Country Macro Economic Indicators |
3.2 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, 2021 & 2031F |
3.3 Finland Induced Pluripotent Stem Cells Market - Industry Life Cycle |
3.4 Finland Induced Pluripotent Stem Cells Market - Porter's Five Forces |
3.5 Finland Induced Pluripotent Stem Cells Market Revenues & Volume Share, By Source Type, 2021 & 2031F |
3.6 Finland Induced Pluripotent Stem Cells Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Finland Induced Pluripotent Stem Cells Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Finland Induced Pluripotent Stem Cells Market Revenues & Volume Share, By Differentiation Capability, 2021 & 2031F |
3.9 Finland Induced Pluripotent Stem Cells Market Revenues & Volume Share, By Research Stage, 2021 & 2031F |
4 Finland Induced Pluripotent Stem Cells Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing research and development activities in the field of induced pluripotent stem cells in Finland |
4.2.2 Growing investments in regenerative medicine and stem cell therapies |
4.2.3 Rising prevalence of chronic diseases driving the demand for innovative treatment options |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and ethical concerns related to the use of induced pluripotent stem cells |
4.3.2 High costs associated with research, development, and commercialization of induced pluripotent stem cell therapies |
5 Finland Induced Pluripotent Stem Cells Market Trends |
6 Finland Induced Pluripotent Stem Cells Market, By Types |
6.1 Finland Induced Pluripotent Stem Cells Market, By Source Type |
6.1.1 Overview and Analysis |
6.1.2 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Source Type, 2021 - 2031F |
6.1.3 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Human iPSCs, 2021 - 2031F |
6.1.4 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Mouse iPSCs, 2021 - 2031F |
6.1.5 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Genetically Modified iPSCs, 2021 - 2031F |
6.1.6 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Tissue-Specific iPSCs, 2021 - 2031F |
6.2 Finland Induced Pluripotent Stem Cells Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Disease Modeling, 2021 - 2031F |
6.2.3 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Drug Discovery, 2021 - 2031F |
6.2.4 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Stem Cell Therapy, 2021 - 2031F |
6.2.5 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.3 Finland Induced Pluripotent Stem Cells Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.3 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Academic Research Centers, 2021 - 2031F |
6.3.4 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.5 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Biotech Companies, 2021 - 2031F |
6.4 Finland Induced Pluripotent Stem Cells Market, By Differentiation Capability |
6.4.1 Overview and Analysis |
6.4.2 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Multipotent, 2021 - 2031F |
6.4.3 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Pluripotent, 2021 - 2031F |
6.4.4 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Totipotent, 2021 - 2031F |
6.4.5 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Oligopotent, 2021 - 2031F |
6.5 Finland Induced Pluripotent Stem Cells Market, By Research Stage |
6.5.1 Overview and Analysis |
6.5.2 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Preclinical Trials, 2021 - 2031F |
6.5.3 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.5.4 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By Commercial Development, 2021 - 2031F |
6.5.5 Finland Induced Pluripotent Stem Cells Market Revenues & Volume, By -Ready Therapies, 2021 - 2031F |
7 Finland Induced Pluripotent Stem Cells Market Import-Export Trade Statistics |
7.1 Finland Induced Pluripotent Stem Cells Market Export to Major Countries |
7.2 Finland Induced Pluripotent Stem Cells Market Imports from Major Countries |
8 Finland Induced Pluripotent Stem Cells Market Key Performance Indicators |
8.1 Number of clinical trials utilizing induced pluripotent stem cells in Finland |
8.2 Adoption rate of induced pluripotent stem cell therapies in clinical settings |
8.3 Number of patents filed for induced pluripotent stem cell technologies in Finland |
8.4 Level of government funding allocated to research and development in the induced pluripotent stem cell field |
8.5 Rate of collaboration between academia, industry, and research institutions in advancing induced pluripotent stem cell technologies |
9 Finland Induced Pluripotent Stem Cells Market - Opportunity Assessment |
9.1 Finland Induced Pluripotent Stem Cells Market Opportunity Assessment, By Source Type, 2021 & 2031F |
9.2 Finland Induced Pluripotent Stem Cells Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Finland Induced Pluripotent Stem Cells Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Finland Induced Pluripotent Stem Cells Market Opportunity Assessment, By Differentiation Capability, 2021 & 2031F |
9.5 Finland Induced Pluripotent Stem Cells Market Opportunity Assessment, By Research Stage, 2021 & 2031F |
10 Finland Induced Pluripotent Stem Cells Market - Competitive Landscape |
10.1 Finland Induced Pluripotent Stem Cells Market Revenue Share, By Companies, 2024 |
10.2 Finland Induced Pluripotent Stem Cells Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |